Jane Street Group, LLC Aveo Pharmaceuticals, Inc. Call Options Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$4.69 - $7.4 $41,272 - $65,120
-8,800 Reduced 31.32%
19,300 $91,000
Q3 2021

Nov 16, 2021
SELL
$5.12 - $6.89 $91,648 - $123,331
-17,900 Reduced 38.91%
28,100 $174,000
Q2 2021

Aug 16, 2021
SELL
$6.21 - $7.45 $176,985 - $212,325
-28,500 Reduced 38.26%
46,000 $303,000
Q1 2021

May 18, 2021
BUY
$5.97 - $15.28 $444,765 - $1.14 Million
74,500 New
74,500 $545,000

Others Institutions Holding AVEO

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About AVEO PHARMACEUTICALS, INC.

AVEO Quotes by TradingView
  • Ticker AVEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,676,000
  • Description
  • AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...
More about AVEO
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email